Sort
82,697 grants matching “vaccine development”
Leveraging membrane Env liposome vaccine design to elicit multi-target cross-neutralization of HIV
$839,102Michael B Zwick · Scripps Research Institute, The · R01 · FY2025 · AI
Project 1 - Profectus Biosciences, Inc.
$839,059John H Eldridge · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2020 · AI
Combined cocaine and HIV vaccine
$839,025Timothy J Cardozo · New York University School Of Medicine · DP1 · FY2016 · DA
Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts
$839,012Bernhard Josef Hering · University Of Minnesota · U01 · FY2013 · AI
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
$838,928Carlos O Esquivel · Stanford University · U01 · FY2018 · AI
Task V04: Clinical Sample Testing Using Intracellular Flow Cytometry using samples from a Phase 1 clinical trial evaluating an influenza vaccine candidate
$838,705Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2019 · AI
Immune Control and Evasion during Acute HCV Infection
$838,700Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2010 · AI
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
$838,489Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2023 · AI
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine
$838,478Kenneth C Bagley · Profectus Biosciences, Inc. · R44 · FY2017 · AI
Early life B cell responses and inflammation following SARS-CoV-2 infection
$838,453Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Development of an Adhesin-Toxoid Chimera Vaccine for Enterotoxigenic E. coli
$838,409Stephen J Savarino · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2008 · AI
Correlates of protective immunity to HCV and rational vaccine design: Project 3
$838,357Rama Rao Amara · Emory University · U19 · FY2024 · AI
Genomics dissection of phenotypic diversity and plasticity of innate immune cell
$838,301John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
VLP Vaccine Technology
$838,288Sang-Moo Kang · Georgia State University · R01 · FY2013 · AI
Institute for Clinical and Translational Research (UL1)
$838,278Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2009 · RR
Evolutionary multispecies transcriptomics to reveal genes that govern fungal spore germination and pathogenesis
$838,160Jeffrey Peter Townsend · Yale University · R01 · FY2019 · AI
Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem
$838,127Jessica Hartman · Cell Microsystems, Inc. · R44 · FY2023 · AI
HIV-1 Env structure and function assessed by parallel smFRET and cryoET
$838,123Walther H Mothes · Yale University · R01 · FY2022 · AI
HIV-1 Env structure and function assessed by parallel smFRET and cryoET
$838,123Walther H Mothes · Yale University · R01 · FY2020 · AI
HIV-1 Env structure and function assessed by parallel smFRET and cryoET
$838,123Walther H Mothes · Yale University · R01 · FY2021 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$838,102Krishna P Reddy · Massachusetts General Hospital · R01 · FY2020 · AI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
$838,091Stephen Philip Schoenberger · La Jolla Institute For Immunology · U01 · FY2022 · DE
SVEU - Final Transition and Continued Operation of the Nonhuman Primate Breeding Colony During Transition
$838,085Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2021 · AI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
$837,967Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2018 · AI
Nonhuman Primate Trials
$837,925Elizabeth Strobert · Emory University · P01 · FY2010 · AI